Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared Chadi Nabhan’s post on X:
“Will ADCs replace chemotherapy?”
Quoting Chadi Nabhan, Chief Medical Officer and Head of Strategy at Ryght, on X:
“This Tuesday 2/24, I am joined by Paolo Tarantino of Dana-Farber News, who discusses “All things ADCs in Cancer.” Wide range conversation that may generate more quetsions. Check out this clip, and mark your calendar this Tuesday morning for the full podcast.”
Other articles featuring Paolo Tarantino and Chadi Nabhan on OncoDaily.